| Document Date: 2013-09-30 13:12:42
Open Document File Size: 22,17 KBShare Result on Facebook
Company IMMUNOMEDICS INC. / IBC Pharmaceuticals Inc. / / Country United States / / Currency USD / / / Event FDA Phase / / Facility Cedars Sinai Medical Center / / / IndustryTerm monoclonal antibody-based products / biopharmaceutical / treatment of lupus / treatment of cancer / autoimmune disease therapies / potential products / clinical trial applications / / MedicalCondition next-generation cancer / serious diseases / cancer / advanced pancreatic cancer / bispecific antibodies targeting cancers / solid tumor / autoimmune disease / infectious diseases / lupus / / MedicalTreatment immunotherapy / / Organization Cedars Sinai Medical Center in Los Angeles / Department of Defense / Securities and Exchange Commission / / Person Morris Plains / Daniel J. Wallace / Cynthia L. Sullivan / Chau Cheng / / / Position Director / President and Chief Executive Officer / principal clinical investigator / Private / principal clinical investigator of this project / / Product 2 antibody-drug / / ProvinceOrState New Jersey / California / / Technology antibodies / Biotechnology / / URL www.immunomedics.com / /
SocialTag |
Microsoft Word - IMMUNOMEDICS AWARDED DOD GRANT FOR MILATUZUMAB IN LUPUS.doc